Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats

British Journal of Pharmacology

Volumn 145, Issue 5, 2005, Pages 587-592

  Owen, Jenny C E ^a   Whitton, Peter S ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

5 HT; Amantadine; Antidepressants; Budipine; Cortex; Microdialysis

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; BUDIPINE; CLOMIPRAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PAROXETINE; REBOXETINE; SEROTONIN;

ACUTE DRUG ADMINISTRATION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; FRONTAL CORTEX; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE;

AMANTADINE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPARKINSON AGENTS; CLOMIPRAMINE; DRUG SYNERGISM; MALE; MICRODIALYSIS; PAROXETINE; PIPERIDINES; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SEROTONIN;

EID: 22744455389     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706188     Document Type: Article

References (38)

1. ADELL, A. & ARTIGAS, F. (1991). Differential effects of clomipramine on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. Naunyn-Schmiedeberg's Arch. Pharmacol., 343, 237-244.
2. ALTAGRACIA, M., ROJAS, P., KRAVZOV, J. & RIOS, C. (1993). Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease. Proc. West. Pharmacol. Soc., 36, 289-291.
3. ANATH, J. (1998). Treatment-resistant depression. Psychother. Psychosomatic, 67, 61-70.
4. BERMAN, R.M., CAPPIELLO, A., ANNAND, A., OREN, D.A., HENINGER, G.R., CHARNEY, D.S. & KRYSTAL, J.H. (2000). Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry, 47, 351-354.
5. BEYER, C.E., BOIKESS, S., LUO, B. & DAWSON, L.A. (2002). Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in vivo microdialysis study. J. Psychopharmacol., 16, 297-304.
6. BLIER, P. & DE MONTIGNY, C. (1994). Current advances and trends in the treatment of depression. Trends Pharmacol. Sci., 15, 230-236.
7. BOYER, P.A., SKOLNICK, P. & FOSSUM, L.H. (1998). Chronic administration of imipramine and citalopram alters the expression of NMDA subunit mRNAs in mouse brain. J. Mol. Neurosci., 10, 219-233.
8. BYMASTER, F.P., ZHANG, W., CARTER, P.A., SHAW. J., CHERNET, E., PHEBUS, L., WONG, D.T. & PERRY, K.W. (2002). Fluoxetine, but not other selective serotonin reuptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology, 160, 353-361.
9. 1A receptors. Br. J. Pharmacol., 142, 469-478.
10. ELTZE, M. (1999). Multiple mechanisms of action: the pharmacological profile of budipine. J. Neural Trans. Suppl., 56, 83-105.
11. FISHER, A. & STARR, M.S. (2000). Opposite effects of glutamate antagonists and antiparkinsonian drugs on the activities of DOPA decarboxylase and 5-HTP decarboxylase in the rat brain. Brain Res., 868, 268-274.
12. GARTSIDE, S.E., CLIFFORD, E.M., COWEN, P.J. & SHARP, T. (1999). Effects of (-)-tertatolol, (-)-penbutolol and (+-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and study. Br. J. Pharmacol., 127, 145-152.
13. HJORTH, S. & AUERBACH, S.S. (1996). 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Behav. Brain. Res., 73, 281-283.
14. LAYER, R.T., POPIK, P., OLDS, T. & SKOLNICK, P. (1995). Antidepressant-like action of the polyamine site antagonist, eliprodil (SL 82015). Pharmacol. Biochem. Behav., 52, 615-620.
15. LEJEUNE, F., GOBERT, A., RIVET, J.M. & MILAN, M.J. (1994). Blockade of transmission of NMDA receptors facilitates the electrical and synthetic activity of ascending serotonergic neurones. Brain Res., 656, 427-431.
16. LE POUL, E., BONI, C., HANOUN, N., LAPORTE, A.M., LAZARIS, N., CHAUVEAU, J. & LANFUMEY, I. (2000). Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology, 39, 110-122.
17. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 141-148.
18. LIEBERMAN, J.A., GREENHOUSE, J., HAMER, R.M., KRISHNAN, K.R., NEMEROFF, O., SHEENAN, D.V., THASE, M.E. & KELLER, M.B. (2005). Comparing the effects of antidepressants: Consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. Neuropsychopharmacology, 30, 445-460.
19. MAJ, J. & ROGOZ, Z. (2000). Synergistic effect of amantadine and imipramine in the forced swimming test. Pol. J. Pharmacol., 52, 111-114.
20. MAJ, J., ROGOZ, Z., SKUZA, G. & SOWINSKA, H. (1992). The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test. Pol. J. Pharmacol., 44, 337-346.
21. MILLAN, M.J., LEJEUNE, F. & GOBERT, A. (2000). Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents. J. Psychopharmacol., 142, 114-138.
22. NAKAYAMA, K. (2002). Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex. Naunyn Schmiedeberg's Arch. Pharmacol., 365, 102-105.
23. 1A autoreceptors. Brain Res., 675, 157-164.
24. PALLOTTA, M., SEGIETH, J. & WHITTON, P.S. (1999a). Chronic but not acute clomipramine alters the effect of NMDA receptor regulation of dopamine release in the rat frontal cortex. Neurosci. Lett., 262, 187-190.
25. PALLOTTA, M., SEGIETH, J. & WHITTON, P.S. (1999b). Chronic clomipramine administration reverses NMDA-evoked decreases in dopamine release in the raphe nuclei. Brain Res., 823, 217-220.
26. PALLOTTA, M., SEGIETH, J., SADIDEEN, F. & WHITTON, P.S. (2001). Repeated but not acute clomipramine decreases the effect of N-methyl-D-aspartate receptor activation on serotonergic transmission between the raphe nuclei and frontal cortex. Neuropharmacology, 41, 294-300.
27. PAPP, P. & MORYL, E. (1994). Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur. J. Pharmacol., 263, 1-7.
28. PAUL, I.A., NOWAK, G., LAYER, R.T., POPIK, P. & SKOLNICK, P. (1994). Adaptation of the N-methyl-D-aspartate complex following chronic antidepressant treatments. J. Pharmacol. Exp. Ther., 269, 95-102.
29. PAXINOS, G. & WATSON, C. (1982). The rat brain in stereotaxic co-ordinates. Academic Press, New York.
30. PORTER, R.H. & GREENAMYRE, J.T. (1995). Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential. J. Neurochem., 64, 614-623.
31. ROGOZ, Z., SKUZA, G., MAJ, J. & DANYSZ, W. (2002). Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats. Neuropharmacology, 42, 1024-1030.
32. ROGOZ, Z., SKUZA, G., KUSMIDERN, M., WOIJICOWSKI, J., KOR, M. & DANYSZ, W. (2004). Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioural and pharmacokinetic studies. Polish J. Pharmacol., 56, 179-185.
33. SKOLNICK, P. (1999). Antidepressants for the new millennium. Eur. J. Pharmacol., 375, 31-40.
34. STRYJER, R., STROUSS, R.D., SHAKED, G., BAR, F., FELDMAN, B., KOTLER, M., POLAK, L., ROSENSCWAIG, S. & WEIZMANN, A. (2003). Amantadine as augmentation therapy in the management of treatment-resistant depression. Int. Clin. Psychopharmacol., 18, 93-96.
35. TAO, R. & AUERBACH, S.B. (1996). Differential effect of NMDA on extracellular serotonin in midbrain raphe and forebrain sites. J. Neurochem., 66, 1067-1075.
36. TRULLAS, R. & SKOLNICK, P. (1990). Functional antagonists of the NMDA receptor complex exhibit antidepressant action. Eur. J. Pharmacol., 185, 1-10.
37. WHITTON, P.S. & FOWLER, L.J. (1991). The effects of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo. Eur. J. Pharmacol., 200, 167-169.
38. WHITTON, P.S., BIGGS, C.S., PEARCE, B.R. & FOWLER, L.J. (1992. MK-801 increases extracellular 5-hydoxytryptamine in rat hippocampus and striatum in vivo. J. Neurochem., 58, 1573-1575.